Myopic Choroidal Neovascularization Membranes Treated With Ranibizumab in Colombian Population
Purpose: To describe the characteristics of myopic choroidal neovascular membranes of hispanic subjects treated with a loading dose of Ranibizumab (Lucentis®). Study design: Non-randomized prospective observational case study. Methods: Five eyes of 5 patients with naïve CNV secondary to pathological...
Main Authors: | Hernan Andres Rios, Anne Brieke, Shirley Rosenstiehl, Francisco Rodriguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | The Pan-American Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.thepajo.org/article.asp?issn=2666-4909;year=2017;volume=16;issue=2;spage=43;epage=45;aulast=Rios;type=0 |
Similar Items
-
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01) -
Role of optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal injections of Ranibizumab
by: Meng Cai, et al.
Published: (2017-10-01) -
Myopic choroidal neovascular membrane: A retrospective study
by: S Sindhu, et al.
Published: (2016-01-01) -
Intravitreal Conbercept or Ranibizumab for myopic choroidal neovascularization
by: Cai-Yun Zhang, et al.
Published: (2022-06-01) -
Intravitreal Ranibizumab Therapy for Choroidal Neovascularization Secondary to Pathological Myopia: 3 Year Outcome
by: İrfan Perente, et al.
Published: (2018-04-01)